Você procurou por: eritropoetin (Maltês - Inglês)

aw pazjent) ġew osservati f ’ pazjenti kkurati b ’ eritropoetin uman rikombinanti.
1.35, 2.06, 35 trials and 6769 patients) was observed in patients treated with recombinant human erythropoietin.

il-piż molekulari apparenti ta’ eritropoetin hu minn 32,000 sa 40,000 dalton.
the apparent molecular weight of erythropoietin is 32,000 to 40,000 dalton.

produzzjoni taċ- ċelluli l- ħomor tad- demm) wara kura b’ xi eritropoetin
following treatment with any erythropoietin

36 kumplikazzjonijiet relatati bejn dawk li ngħataw eritropoetin rikombinanti uman u dawk fil- grupp ta ’ kontroll.
overall survival outcome in the trials could not be satisfactorily explained by differences in the incidence of thrombosis and related complications between those given recombinant human erythropoietin and those in the control group.

eritropoetin huwa fattur tat-tkabbir li primarjament jistimola l-produzzjoni ta’ ċelluli ħomor.
erythropoietin is a growth factor that primarily stimulates red cell production.

riċetturi għal eritropoetin jistgħu jinstabu fuq il-wiċċ ta’ varjetà ta’ ċelluli tat-tumur.
erythropoietin receptors may be expressed on the surface of a variety of tumour cells.

eritropoetin hu glikoproteina li tistimola l- formazzjoni ta ’ ċelluli ħomor tad- demm mill- proġenituri tagħhom.
erythropoietin is a glycoprotein that stimulates the formation of erythrocytes from its committed progenitors.

l-mah għandu jipprovdi ttestjar b’xejn għall-antikorpi kontra eritropoetin lit-tobba fuq talba tagħhom.
the mah shall provide physicians upon their request with free anti-erythropoietin antibody testing.

jekk tkun issuspettata prca medjata b’ antikorpi kontra l- eritropoetin, it- terapija b’ abseamed għandha titwaqqaf immedjatament.
if anti-erythropoietin, antibody-mediated prca is suspected, therapy with abseamed should be discontinued immediately.

1. 35, 2. 06, 35 prova u 6769 pazjent) kienet osservata f’ pazjenti kkurati b’ eritropoetin rikombinanti umana.
in the absence of compatibility studies, this medicinal product should not be mixed with other medicinal products.

13 aplasija pura taċ- Ċelluli l- Ħomor ikkawżata minn antikorpi anti- eritropoetin, kienet irrappurtata f’ assoċjazzjoni ma ’ esas.
pure red cell aplasia caused by anti-erythropoietin antibodies has been reported in association with esas.

aplasija pura taċ-ċelluli l-ħomor (prca) medjata minn antikorpi newtralizzanti anti-eritropoetin ġiet irrappurtata, frekwenza mhux magħrufa.
neutralising anti-erythropoietin antibody-mediated pure red cell aplasia (prca) has been reported, frequency unknown.

b’rispons għall-ipoxja, l- ormon naturali eritropoetin jinteraġixxi ma’ ċelluli proġenituri eritroidi biex tiżdied il-produzzjoni taċ- ċelluli ħomor.
in responding to hypoxia, the natural hormone erythropoietin interacts with erythroid progenitor cells to increase red cell production.